View Financial HealthIBU-tec advanced materials 配当と自社株買い配当金 基準チェック /16IBU-tec advanced materialsは配当を支払う会社で、現在の利回りは0.74%です。前回の支払いは 22nd May, 2026で、権利落ち日は20th May, 2026 。主要情報0.7%配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長-12.0%次回配当支払日22 May 26配当落ち日20 May 26一株当たり配当金n/a配当性向9,992%最近の配当と自社株買いの更新お知らせ • Apr 09+ 1 more updateIBU-tec advanced materials AG announces Annual dividend, payable on May 22, 2026IBU-tec advanced materials AG announced Annual dividend of EUR 0.1200 per share payable on May 22, 2026, ex-date on May 20, 2026 and record date on May 21, 2026.Upcoming Dividend • Apr 20Upcoming dividend of €0.04 per share at 0.1% yieldEligible shareholders must have bought the stock before 27 April 2023. Payment date: 02 May 2023. Trailing yield: 0.1%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.3%).すべての更新を表示Recent updatesPrice Target Changed • May 20Price target increased by 238% to €25.00Up from €7.40, the current price target is provided by 1 analyst. New target price is 60% above last closing price of €15.65. Stock is up 123% over the past year. The company is forecast to post a net loss per share of €0.44 compared to earnings per share of €0.0012 last year.お知らせ • Apr 09+ 1 more updateIBU-tec advanced materials AG announces Annual dividend, payable on May 22, 2026IBU-tec advanced materials AG announced Annual dividend of EUR 0.1200 per share payable on May 22, 2026, ex-date on May 20, 2026 and record date on May 21, 2026.お知らせ • Mar 30+ 1 more updateIBU-tec advanced materials AG to Report Fiscal Year 2025 Results on Apr 08, 2026IBU-tec advanced materials AG announced that they will report fiscal year 2025 results at 12:00 PM, Central European Standard Time on Apr 08, 2026お知らせ • Jun 24IBU-tec advanced materials AG to Report First Half, 2025 Results on Aug 27, 2025IBU-tec advanced materials AG announced that they will report first half, 2025 results on Aug 27, 2025お知らせ • Apr 17IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025, at 10:00 W. Europe Standard Time.お知らせ • Apr 16Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures.お知らせ • Jan 08IBU-tec advanced materials AG to Report Fiscal Year 2024 Results on Mar 20, 2025IBU-tec advanced materials AG announced that they will report fiscal year 2024 results at 12:00 PM, Central European Standard Time on Mar 20, 2025Price Target Changed • Dec 30Price target decreased by 38% to €7.40Down from €12.00, the current price target is provided by 1 analyst. New target price is 13% above last closing price of €6.52. Stock is down 64% over the past year. The company posted a net loss per share of €0.52 last year.Reported Earnings • Sep 01First half 2024 earnings released: €0.66 loss per share (vs €0.078 profit in 1H 2023)First half 2024 results: €0.66 loss per share (down from €0.078 profit in 1H 2023). Revenue: €25.3m (down 1.1% from 1H 2023). Net loss: €3.15m (down €3.53m from profit in 1H 2023). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 25 percentage points per year, which is a significant difference in performance.お知らせ • Aug 29IBU-tec advanced materials AG to Report First Half, 2024 Results on Aug 27, 2024IBU-tec advanced materials AG announced that they will report first half, 2024 results on Aug 27, 2024お知らせ • Mar 22IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024.Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improves as stock rises 22%After last week's 22% share price gain to €11.46, the stock trades at a trailing P/E ratio of 51.8x. Average forward P/E is 18x in the Chemicals industry in Germany. Total loss to shareholders of 74% over the past three years.お知らせ • Mar 21IBU-tec advanced materials AG to Report Fiscal Year 2023 Results on Mar 21, 2024IBU-tec advanced materials AG announced that they will report fiscal year 2023 results on Mar 21, 2024New Risk • Mar 12New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). High level of non-cash earnings (22% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€47.5m market cap, or US$51.9m).Valuation Update With 7 Day Price Move • Jan 29Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €15.98, the stock trades at a trailing P/E ratio of 65.2x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 56% over the past three years.Valuation Update With 7 Day Price Move • Jan 13Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €13.68, the stock trades at a trailing P/E ratio of 56.9x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 44% over the past three years.New Risk • Dec 09New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €90.7m (US$97.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€90.7m market cap, or US$97.7m).Valuation Update With 7 Day Price Move • Oct 20Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to €18.00, the stock trades at a forward P/E ratio of 62x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 42% over the past three years.Reported Earnings • Aug 30First half 2023 earnings released: EPS: €0.078 (vs €0.10 in 1H 2022)First half 2023 results: EPS: €0.078 (down from €0.10 in 1H 2022). Revenue: €25.5m (down 14% from 1H 2022). Net income: €372.8k (down 24% from 1H 2022). Profit margin: 1.5% (down from 1.7% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.New Risk • Aug 28New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (22% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change).Upcoming Dividend • Apr 20Upcoming dividend of €0.04 per share at 0.1% yieldEligible shareholders must have bought the stock before 27 April 2023. Payment date: 02 May 2023. Trailing yield: 0.1%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.3%).Reported Earnings • Mar 27Full year 2022 earnings releasedFull year 2022 results: Revenue: €56.0m (up 26% from FY 2021). Net income: €1.28m (up €1.52m from FY 2021). Profit margin: 2.3% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Chemicals industry in Germany.Price Target Changed • Nov 16Price target decreased to €58.00Down from €64.50, the current price target is provided by 1 analyst. New target price is 119% above last closing price of €26.50. Stock is down 38% over the past year. The company is forecast to post earnings per share of €0.13 next year compared to a net loss per share of €0.049 last year.Valuation Update With 7 Day Price Move • Oct 08Investor sentiment improved over the past weekAfter last week's 20% share price gain to €19.06, the stock trades at a forward P/E ratio of 58x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 14% over the past three years.Valuation Update With 7 Day Price Move • Sep 17Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €17.56, the stock trades at a forward P/E ratio of 54x. Average forward P/E is 9x in the Chemicals industry in Germany. Total returns to shareholders of 5.0% over the past three years.Reported Earnings • Sep 02First half 2022 earnings released: EPS: €0 (vs €0.23 loss in 1H 2021)First half 2022 results: EPS: €0 (up from €0.23 loss in 1H 2021). Revenue: €30.7m (up 53% from 1H 2021). Net income: €491.3k (up €1.60m from 1H 2021). Profit margin: 1.6% (up from net loss in 1H 2021). Over the next year, revenue is forecast to grow 17%, compared to a 2.3% growth forecast for the Chemicals industry in Germany.Reported Earnings • Apr 29Full year 2021 earnings releasedFull year 2021 results: Revenue: €47.6m (up 45% from FY 2020). Net loss: €234.6k (down 123% from profit in FY 2020). Over the next year, revenue is forecast to grow 19%, compared to a 10% growth forecast for the industry in Germany.Price Target Changed • Apr 27Price target increased to €64.50Up from €38.73, the current price target is provided by 1 analyst. New target price is 88% above last closing price of €34.35. Stock is down 17% over the past year. The company is forecast to post earnings per share of €0.16 for next year compared to €0.25 last year.Reported Earnings • Mar 21Full year 2020 earnings releasedThe company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: €42.2m (down 14% from FY 2019). Net income: €1.00m (up 16% from FY 2019). Profit margin: 2.4% (up from 1.8% in FY 2019). The increase in margin was driven by lower expenses.Is New 90 Day High Low • Feb 02New 90-day high: €38.40The company is up 146% from its price of €15.60 on 04 November 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €121 per share.Price Target Changed • Jan 27Price target raised to €28.07Up from €18.10, the current price target is an average from 3 analysts. The new target price is 20% below the current share price of €35.20. As of last close, the stock is up 135% over the past year.Valuation Update With 7 Day Price Move • Dec 11Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €29.20, the stock is trading at a trailing P/E ratio of 70.3x, down from the previous P/E ratio of 85.2x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 74%.Valuation Update With 7 Day Price Move • Dec 05Market bids up stock over the past weekAfter last week's 29% share price gain to €35.40, the stock is trading at a trailing P/E ratio of 79.4x, up from the previous P/E ratio of 61.5x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 115%.Valuation Update With 7 Day Price Move • Dec 03Market bids up stock over the past weekAfter last week's 23% share price gain to €35.60, the stock is trading at a trailing P/E ratio of 76.7x, up from the previous P/E ratio of 62.5x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 116%.Valuation Update With 7 Day Price Move • Nov 30Market pulls back on stock over the past weekAfter last week's 16% share price decline to €27.40, the stock is trading at a trailing P/E ratio of 64.4x, down from the previous P/E ratio of 76.6x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 70%.Valuation Update With 7 Day Price Move • Nov 19Market bids up stock over the past weekAfter last week's 18% share price gain to €18.70, the stock is trading at a trailing P/E ratio of 42.7x, up from the previous P/E ratio of 36.3x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 10%.Is New 90 Day High Low • Nov 12New 90-day high: €16.60The company is up 52% from its price of €10.90 on 14 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.81 per share.Valuation Update With 7 Day Price Move • Nov 02Market bids up stock over the past weekAfter last week's 29% share price gain to €16.50, the stock is trading at a trailing P/E ratio of 32x, up from the previous P/E ratio of 24.8x. This compares to an average P/E of 24x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 4.0%.Valuation Update With 7 Day Price Move • Oct 22Market bids up stock over the past weekAfter last week's 20% share price gain to €13.30, the stock is trading at a trailing P/E ratio of 30.4x, up from the previous P/E ratio of 25.3x. This compares to an average P/E of 31x in the Chemicals industry in Germany. Total return to shareholders over the past three years is a loss of 19%.Valuation Update With 7 Day Price Move • Oct 19Market bids up stock over the past weekAfter last week's 16% share price gain to €13.40, the stock is trading at a trailing P/E ratio of 30.1x, up from the previous P/E ratio of 26.1x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total return to shareholders over the past three years is a loss of 16%.Is New 90 Day High Low • Oct 19New 90-day high: €13.40The company is up 19% from its price of €11.30 on 21 July 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €5.88 per share.決済の安定と成長配当データの取得安定した配当: IBUは 10 年未満配当金を支払っており、この間、支払額は 変動性 が高かった。増加する配当: IBUは8年間のみ配当金を支払っており、それ以降は支払額が減少しています。配当利回り対市場IBU-tec advanced materials 配当利回り対市場IBU 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (IBU)0.7%市場下位25% (DE)1.5%市場トップ25% (DE)4.5%業界平均 (Chemicals)3.7%アナリスト予想 (IBU) (最長3年)n/a注目すべき配当: IBUの配当金 ( 0.74% ) はGerman市場の配当金支払者の下位 25% ( 1.54% ) と比べると目立ったものではありません。高配当: IBUの配当金 ( 0.74% ) はGerman市場の配当金支払者の上位 25% ( 4.55% ) と比較すると低いです。株主への利益配当収益カバレッジ: IBUは高い 配当性向 ( 9991.7% ) のため、配当金の支払いは利益によって十分にカバーされていません。株主配当金キャッシュフローカバレッジ: IBUは 現金配当性向 ( 12.3% ) が低いため、配当金の支払いはキャッシュフローによって完全にカバーされています。高配当企業の発掘7D1Y7D1Y7D1YDE 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 16:22終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋IBU-tec advanced materials AG 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Patrick SpeckMontega AGOliver SchwarzWarburg Research GmbH
お知らせ • Apr 09+ 1 more updateIBU-tec advanced materials AG announces Annual dividend, payable on May 22, 2026IBU-tec advanced materials AG announced Annual dividend of EUR 0.1200 per share payable on May 22, 2026, ex-date on May 20, 2026 and record date on May 21, 2026.
Upcoming Dividend • Apr 20Upcoming dividend of €0.04 per share at 0.1% yieldEligible shareholders must have bought the stock before 27 April 2023. Payment date: 02 May 2023. Trailing yield: 0.1%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.3%).
Price Target Changed • May 20Price target increased by 238% to €25.00Up from €7.40, the current price target is provided by 1 analyst. New target price is 60% above last closing price of €15.65. Stock is up 123% over the past year. The company is forecast to post a net loss per share of €0.44 compared to earnings per share of €0.0012 last year.
お知らせ • Apr 09+ 1 more updateIBU-tec advanced materials AG announces Annual dividend, payable on May 22, 2026IBU-tec advanced materials AG announced Annual dividend of EUR 0.1200 per share payable on May 22, 2026, ex-date on May 20, 2026 and record date on May 21, 2026.
お知らせ • Mar 30+ 1 more updateIBU-tec advanced materials AG to Report Fiscal Year 2025 Results on Apr 08, 2026IBU-tec advanced materials AG announced that they will report fiscal year 2025 results at 12:00 PM, Central European Standard Time on Apr 08, 2026
お知らせ • Jun 24IBU-tec advanced materials AG to Report First Half, 2025 Results on Aug 27, 2025IBU-tec advanced materials AG announced that they will report first half, 2025 results on Aug 27, 2025
お知らせ • Apr 17IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025, at 10:00 W. Europe Standard Time.
お知らせ • Apr 16Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures.
お知らせ • Jan 08IBU-tec advanced materials AG to Report Fiscal Year 2024 Results on Mar 20, 2025IBU-tec advanced materials AG announced that they will report fiscal year 2024 results at 12:00 PM, Central European Standard Time on Mar 20, 2025
Price Target Changed • Dec 30Price target decreased by 38% to €7.40Down from €12.00, the current price target is provided by 1 analyst. New target price is 13% above last closing price of €6.52. Stock is down 64% over the past year. The company posted a net loss per share of €0.52 last year.
Reported Earnings • Sep 01First half 2024 earnings released: €0.66 loss per share (vs €0.078 profit in 1H 2023)First half 2024 results: €0.66 loss per share (down from €0.078 profit in 1H 2023). Revenue: €25.3m (down 1.1% from 1H 2023). Net loss: €3.15m (down €3.53m from profit in 1H 2023). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 25 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 29IBU-tec advanced materials AG to Report First Half, 2024 Results on Aug 27, 2024IBU-tec advanced materials AG announced that they will report first half, 2024 results on Aug 27, 2024
お知らせ • Mar 22IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024.
Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improves as stock rises 22%After last week's 22% share price gain to €11.46, the stock trades at a trailing P/E ratio of 51.8x. Average forward P/E is 18x in the Chemicals industry in Germany. Total loss to shareholders of 74% over the past three years.
お知らせ • Mar 21IBU-tec advanced materials AG to Report Fiscal Year 2023 Results on Mar 21, 2024IBU-tec advanced materials AG announced that they will report fiscal year 2023 results on Mar 21, 2024
New Risk • Mar 12New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). High level of non-cash earnings (22% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€47.5m market cap, or US$51.9m).
Valuation Update With 7 Day Price Move • Jan 29Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €15.98, the stock trades at a trailing P/E ratio of 65.2x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 56% over the past three years.
Valuation Update With 7 Day Price Move • Jan 13Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €13.68, the stock trades at a trailing P/E ratio of 56.9x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 44% over the past three years.
New Risk • Dec 09New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €90.7m (US$97.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€90.7m market cap, or US$97.7m).
Valuation Update With 7 Day Price Move • Oct 20Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to €18.00, the stock trades at a forward P/E ratio of 62x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 42% over the past three years.
Reported Earnings • Aug 30First half 2023 earnings released: EPS: €0.078 (vs €0.10 in 1H 2022)First half 2023 results: EPS: €0.078 (down from €0.10 in 1H 2022). Revenue: €25.5m (down 14% from 1H 2022). Net income: €372.8k (down 24% from 1H 2022). Profit margin: 1.5% (down from 1.7% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.
New Risk • Aug 28New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (22% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change).
Upcoming Dividend • Apr 20Upcoming dividend of €0.04 per share at 0.1% yieldEligible shareholders must have bought the stock before 27 April 2023. Payment date: 02 May 2023. Trailing yield: 0.1%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.3%).
Reported Earnings • Mar 27Full year 2022 earnings releasedFull year 2022 results: Revenue: €56.0m (up 26% from FY 2021). Net income: €1.28m (up €1.52m from FY 2021). Profit margin: 2.3% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Chemicals industry in Germany.
Price Target Changed • Nov 16Price target decreased to €58.00Down from €64.50, the current price target is provided by 1 analyst. New target price is 119% above last closing price of €26.50. Stock is down 38% over the past year. The company is forecast to post earnings per share of €0.13 next year compared to a net loss per share of €0.049 last year.
Valuation Update With 7 Day Price Move • Oct 08Investor sentiment improved over the past weekAfter last week's 20% share price gain to €19.06, the stock trades at a forward P/E ratio of 58x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 14% over the past three years.
Valuation Update With 7 Day Price Move • Sep 17Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €17.56, the stock trades at a forward P/E ratio of 54x. Average forward P/E is 9x in the Chemicals industry in Germany. Total returns to shareholders of 5.0% over the past three years.
Reported Earnings • Sep 02First half 2022 earnings released: EPS: €0 (vs €0.23 loss in 1H 2021)First half 2022 results: EPS: €0 (up from €0.23 loss in 1H 2021). Revenue: €30.7m (up 53% from 1H 2021). Net income: €491.3k (up €1.60m from 1H 2021). Profit margin: 1.6% (up from net loss in 1H 2021). Over the next year, revenue is forecast to grow 17%, compared to a 2.3% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Apr 29Full year 2021 earnings releasedFull year 2021 results: Revenue: €47.6m (up 45% from FY 2020). Net loss: €234.6k (down 123% from profit in FY 2020). Over the next year, revenue is forecast to grow 19%, compared to a 10% growth forecast for the industry in Germany.
Price Target Changed • Apr 27Price target increased to €64.50Up from €38.73, the current price target is provided by 1 analyst. New target price is 88% above last closing price of €34.35. Stock is down 17% over the past year. The company is forecast to post earnings per share of €0.16 for next year compared to €0.25 last year.
Reported Earnings • Mar 21Full year 2020 earnings releasedThe company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: €42.2m (down 14% from FY 2019). Net income: €1.00m (up 16% from FY 2019). Profit margin: 2.4% (up from 1.8% in FY 2019). The increase in margin was driven by lower expenses.
Is New 90 Day High Low • Feb 02New 90-day high: €38.40The company is up 146% from its price of €15.60 on 04 November 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €121 per share.
Price Target Changed • Jan 27Price target raised to €28.07Up from €18.10, the current price target is an average from 3 analysts. The new target price is 20% below the current share price of €35.20. As of last close, the stock is up 135% over the past year.
Valuation Update With 7 Day Price Move • Dec 11Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €29.20, the stock is trading at a trailing P/E ratio of 70.3x, down from the previous P/E ratio of 85.2x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 74%.
Valuation Update With 7 Day Price Move • Dec 05Market bids up stock over the past weekAfter last week's 29% share price gain to €35.40, the stock is trading at a trailing P/E ratio of 79.4x, up from the previous P/E ratio of 61.5x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 115%.
Valuation Update With 7 Day Price Move • Dec 03Market bids up stock over the past weekAfter last week's 23% share price gain to €35.60, the stock is trading at a trailing P/E ratio of 76.7x, up from the previous P/E ratio of 62.5x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 116%.
Valuation Update With 7 Day Price Move • Nov 30Market pulls back on stock over the past weekAfter last week's 16% share price decline to €27.40, the stock is trading at a trailing P/E ratio of 64.4x, down from the previous P/E ratio of 76.6x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 70%.
Valuation Update With 7 Day Price Move • Nov 19Market bids up stock over the past weekAfter last week's 18% share price gain to €18.70, the stock is trading at a trailing P/E ratio of 42.7x, up from the previous P/E ratio of 36.3x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 10%.
Is New 90 Day High Low • Nov 12New 90-day high: €16.60The company is up 52% from its price of €10.90 on 14 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.81 per share.
Valuation Update With 7 Day Price Move • Nov 02Market bids up stock over the past weekAfter last week's 29% share price gain to €16.50, the stock is trading at a trailing P/E ratio of 32x, up from the previous P/E ratio of 24.8x. This compares to an average P/E of 24x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 4.0%.
Valuation Update With 7 Day Price Move • Oct 22Market bids up stock over the past weekAfter last week's 20% share price gain to €13.30, the stock is trading at a trailing P/E ratio of 30.4x, up from the previous P/E ratio of 25.3x. This compares to an average P/E of 31x in the Chemicals industry in Germany. Total return to shareholders over the past three years is a loss of 19%.
Valuation Update With 7 Day Price Move • Oct 19Market bids up stock over the past weekAfter last week's 16% share price gain to €13.40, the stock is trading at a trailing P/E ratio of 30.1x, up from the previous P/E ratio of 26.1x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total return to shareholders over the past three years is a loss of 16%.
Is New 90 Day High Low • Oct 19New 90-day high: €13.40The company is up 19% from its price of €11.30 on 21 July 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €5.88 per share.